Opportunity Information: Apply for PA 11 014

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "HIV Infection of the Central Nervous System (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.273 Alcohol Research Programs 93.279 Drug Abuse and Addiction Research Programs 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders.
  • This funding opportunity was created on Oct 26, 2010 and posted on Oct 26, 2010.
  • Applicants must submit their applications by Jan 7, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: For profit organizations other than small businesses Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Private institutions of higher education Special district governments Independent school districts State governments County governments Others (see text field entitled Additional Information on Eligibility for clarification).
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PA 11 014

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The HIV Infection of the Central Nervous System (R01) opportunity (Funding Opportunity Number PA-11-014) is an NIH research grant program that supported projects aimed at understanding how HIV-1 affects the brain and nervous system and how those effects can be prevented or treated. The participating NIH institutes were NIMH, NIAAA, NIDA, and NINDS, reflecting a strong emphasis on the mental health, substance use, neurological, and neurobehavioral dimensions of HIV-related disease. The scientific focus centers on HIV-1 Associated Neurocognitive Disorders (HAND), a spectrum of cognitive, behavioral, and neurological problems linked to HIV infection of the central nervous system (CNS). The overall goal of the program was to fund studies that clarify the underlying disease mechanisms in the CNS and translate that knowledge into improved diagnostic and therapeutic strategies.

Projects were encouraged to address the pathogenic mechanisms that drive HAND, meaning the biological and physiological processes that lead from HIV infection to changes in brain function and behavior. This can include investigating viral and host factors that contribute to CNS infection, inflammation, neuronal injury, and cognitive decline, as well as understanding how HIV persists or causes damage in the context of antiretroviral therapy. The announcement also emphasized identifying therapeutic strategies, which can range from interventions that directly target viral activity in the CNS to approaches that reduce neuroinflammation, protect neurons, or improve cognitive and functional outcomes. Importantly, the program welcomed a wide range of research approaches, from foundational basic science studies through applied and clinical research focused on diagnosis and treatment, and it allowed work to be conducted in both domestic and international settings.

The funding mechanism was the NIH R01, a standard research project grant intended for hypothesis-driven, investigator-initiated studies with a defined scope of work. The opportunity fell under the broad activity category of education and health and aligned with several CFDA program areas, including mental health research grants (93.242), alcohol research programs (93.273), drug abuse and addiction research programs (93.279), and extramural neuroscience and neurological disorder research programs (93.853). No cost sharing or matching was required, which typically means applicants were not expected to commit non-federal funds as a condition of the award.

Eligibility was broad and included many types of applicant organizations. Eligible applicants included public and private institutions of higher education, nonprofit organizations (with and without 501(c)(3) status), for-profit organizations (including small businesses and other for-profits), and numerous government entities such as city or township governments, counties, states, special district governments, and independent school districts. The announcement also explicitly included tribal governments and tribal organizations, public housing authorities, and a variety of mission-focused institutions and communities. Additional eligible groups listed included Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities (TCCUs), faith-based and community-based organizations, U.S. territories or possessions, and non-U.S. entities such as foreign organizations and regional organizations. This broad eligibility signaled an interest in supporting diverse research environments and encouraging global participation where scientifically appropriate.

While the program encouraged multidisciplinary research teams and collaborative alliances, collaboration was not a requirement. In practice, this language often supports proposals that integrate multiple disciplines such as neurology, psychiatry, neuroimmunology, virology, neuropsychology, addiction science, imaging, biomarkers, pharmacology, and clinical care. The intent was to promote work that can connect mechanistic insights with real-world clinical problems, including how neurocognitive impairment is identified, monitored, and treated in people living with HIV, and how co-occurring factors like alcohol use and substance use may influence CNS outcomes.

Administratively, the opportunity was posted and created on October 26, 2010. The original and final closing date listed was January 7, 2014, and the announcement was archived on February 7, 2014, meaning it is no longer accepting applications under that specific solicitation. The sponsoring agency was the National Institutes of Health. For applicants needing help accessing the full announcement or troubleshooting links, the listing referenced the NIH Office of Extramural Research (OER) Webmaster contact (FBOWebmaster@OD.NIH.GOV) and provided an additional information link to the archived funding announcement on the NIH grants site.

Frequently Asked Questions (FAQ)

What is the "HIV Infection of the Central Nervous System (R01)" opportunity?

This opportunity (Funding Opportunity Number PA-11-014) was a National Institutes of Health (NIH) research grant program that supported studies on how HIV-1 affects the brain and nervous system, and how those effects can be prevented, diagnosed, or treated.

What is the main scientific topic this program focused on?

The central scientific focus was HIV-1 Associated Neurocognitive Disorders (HAND), which describes a spectrum of cognitive, behavioral, and neurological problems linked to HIV infection of the central nervous system (CNS).

What was the overall goal of the program?

The goal was to fund research that clarifies the mechanisms of HIV-related disease in the CNS and translates that knowledge into improved diagnostic and therapeutic strategies for people affected by HAND.

Which NIH institutes participated in this funding opportunity?

The participating NIH institutes were:

  • NIMH (National Institute of Mental Health)
  • NIAAA (National Institute on Alcohol Abuse and Alcoholism)
  • NIDA (National Institute on Drug Abuse)
  • NINDS (National Institute of Neurological Disorders and Stroke)

This mix reflects an emphasis on mental health, substance use, neurological, and neurobehavioral dimensions of HIV-related CNS disease.

What kinds of research projects were encouraged?

Projects were encouraged to address the pathogenic mechanisms that drive HAND, including biological and physiological processes connecting HIV infection to changes in brain function and behavior. Examples of encouraged directions included studies of viral and host factors involved in CNS infection, inflammation, neuronal injury, and cognitive decline, including work that examines HIV persistence or ongoing damage in the context of antiretroviral therapy.

Did the program emphasize treatment development or only basic science?

It included both. The announcement emphasized identifying therapeutic strategies, which could range from approaches targeting viral activity in the CNS to interventions that reduce neuroinflammation, protect neurons, or improve cognitive and functional outcomes. At the same time, it welcomed foundational basic science that helps explain underlying CNS disease mechanisms.

What types of research approaches were allowed?

A wide range of approaches were welcomed, spanning basic science through applied and clinical research focused on diagnosis and treatment. The intent was to support work that can connect mechanistic insights to real-world clinical problems.

Could the research be conducted outside the United States?

Yes. The program allowed work to be conducted in both domestic and international settings, and eligibility explicitly included non-U.S. entities such as foreign organizations and regional organizations.

What funding mechanism did this program use?

The funding mechanism was an NIH R01, which is a standard research project grant intended for hypothesis-driven, investigator-initiated studies with a defined scope of work.

Was cost sharing or matching required?

No. The opportunity stated that no cost sharing or matching was required, meaning applicants were not expected to commit non-federal funds as a condition of the award.

What CFDA program areas did this opportunity align with?

The opportunity aligned with several CFDA program areas, including:

  • 93.242 (Mental Health Research Grants)
  • 93.273 (Alcohol Research Programs)
  • 93.279 (Drug Abuse and Addiction Research Programs)
  • 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders)

Who was eligible to apply?

Eligibility was broad and included many types of organizations, such as:

  • Public and private institutions of higher education
  • Nonprofit organizations (with and without 501(c)(3) status)
  • For-profit organizations (including small businesses and other for-profits)
  • Government entities (city or township governments, counties, states, special districts, independent school districts)
  • Tribal governments and tribal organizations
  • Public housing authorities
  • U.S. territories or possessions
  • Foreign organizations and regional organizations (non-U.S. entities)

Did the announcement encourage applications from specific institution types or communities?

Yes. The eligibility list explicitly included mission-focused institutions and communities such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and tribally controlled colleges and universities (TCCUs). It also included faith-based and community-based organizations.

Was collaboration required for this R01 opportunity?

No. The program encouraged multidisciplinary research teams and collaborative alliances, but collaboration was not a requirement.

What kinds of multidisciplinary collaborations were envisioned?

The language supported proposals integrating multiple disciplines relevant to HIV and the CNS, such as neurology, psychiatry, neuroimmunology, virology, neuropsychology, addiction science, imaging, biomarkers, pharmacology, and clinical care.

How did the program connect CNS research to real-world clinical issues?

The intent was to promote research linking mechanisms to clinical problems, including how neurocognitive impairment is identified, monitored, and treated in people living with HIV, and how co-occurring factors like alcohol use and substance use may influence CNS outcomes.

When was this opportunity posted and when did it close?

The opportunity was posted and created on October 26, 2010. The original and final closing date listed was January 7, 2014.

Is this funding opportunity still accepting applications?

No. The announcement was archived on February 7, 2014, which indicates it is no longer accepting applications under that specific solicitation (PA-11-014).

Who was the sponsoring agency?

The sponsoring agency was the National Institutes of Health (NIH).

Where could applicants go for help accessing the full announcement or fixing link issues?

The listing referenced the NIH Office of Extramural Research (OER) Webmaster contact for help: FBOWebmaster@OD.NIH.GOV. It also referenced an additional information link to the archived funding announcement on the NIH grants site.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Pre Travel Health Improving and Expanding the Implementation of Counseling and Surveillance of International Travelers

Previous opportunity: Weir Farm National Historic Site, CT Dry Stone Masonry Services

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 11 014

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 11 014) also looked into and applied for these:

Funding Opportunity
National Gene Vector Biorepository and Coordinating Center (P40) Apply for RFA RR 10 010

Funding Number: RFA RR 10 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medical Marijuana Policy Research Exploring Trends and Impacts (R01) Apply for RFA DA 11 008

Funding Number: RFA DA 11 008
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Molecular Genetics of Drug Addiction and Related Co Morbidities (R01) Apply for PA 11 026

Funding Number: PA 11 026
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Support Opportunity for Addiction Research (SOAR) for New Investigators (R03) Apply for RFA DA 11 010

Funding Number: RFA DA 11 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse (R01) Apply for PA 11 027

Funding Number: PA 11 027
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Continued Development and Maintenance of Software (R01) Apply for PAR 11 028

Funding Number: PAR 11 028
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Statistical Coordination Center for the Population based Research Optimizing Screening through Personalized Regimens (PROSPR)(U01) Apply for RFA CA 11 004

Funding Number: RFA CA 11 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Population based Research Optimizing Screening through Personalized Regimens (PROSPR) (U54) Apply for RFA CA 11 003

Funding Number: RFA CA 11 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R21) Apply for PA 11 034

Funding Number: PA 11 034
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $275,000
Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R03) Apply for PA 11 035

Funding Number: PA 11 035
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Institutional Clinical and Translational Science Award (U54) Apply for RFA RM 10 020

Funding Number: RFA RM 10 020
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition Fogarty International Research Collaboration Behavioral and Social Sciences (FIRCA BSS) Research Award (R03) Apply for PAR 11 036

Funding Number: PAR 11 036
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Apply for PA 11 047

Funding Number: PA 11 047
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Apply for PA 11 048

Funding Number: PA 11 048
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Apply for PA 11 049

Funding Number: PA 11 049
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition Extramural Research Facilities Improvement Program (C06) Apply for RFA RR 11 001

Funding Number: RFA RR 11 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $1,500,000
Diversity promoting Institutions Drug Abuse Research Program (DIDARP) (R24) Apply for PAR 11 060

Funding Number: PAR 11 060
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $350,000
Advanced In Vivo Imaging to Understand Cancer Systems (R01) Apply for RFA CA 11 005

Funding Number: RFA CA 11 005
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R01) Apply for PA 11 073

Funding Number: PA 11 073
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21) Apply for PA 11 074

Funding Number: PA 11 074
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 11 014", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.